These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 18359354)

  • 61. Treatment of pachyonychia congenita with plantar injections of botulinum toxin.
    Swartling C; Vahlquist A
    Br J Dermatol; 2006 Apr; 154(4):763-5. PubMed ID: 16536826
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Clinical aspects and treatment of 95 patients with hemifacial spasm].
    Badarny S; Kidan H; Honigman S; Giladi N
    Harefuah; 2002 Mar; 141(3):239-41, 315. PubMed ID: 11944214
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Treatment of depression with botulinum toxin A: a case series.
    Finzi E; Wasserman E
    Dermatol Surg; 2006 May; 32(5):645-9; discussion 649-50. PubMed ID: 16706759
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The role of botulinum toxin in the management of head and neck cancer patients.
    Laskawi R; Ellies M
    Curr Opin Otolaryngol Head Neck Surg; 2007 Apr; 15(2):112-6. PubMed ID: 17413413
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The successful use of botulinum toxin for the treatment of nasal hyperhidrosis.
    Geddoa E; Balakumar AK; Paes TR
    Int J Dermatol; 2008 Oct; 47(10):1079-80. PubMed ID: 18986362
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Lower facial contouring with botulinum toxin type A.
    Tartaro G; Rauso R; Santagata M; Santillo V; Itro A
    J Craniofac Surg; 2008 Nov; 19(6):1613-7. PubMed ID: 19098563
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Focal hyperhidrosis of the anal fold: successful treatment with botulinum toxin A.
    Bechara FG; Sand M; Achenbach RK; Sand D; Altmeyer P; Hoffmann K
    Dermatol Surg; 2007 Aug; 33(8):924-7. PubMed ID: 17661934
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Botulinum toxin A for treating muscular contractures in cephalic tetanus.
    García-García A; Gándara-Rey JM; Crespo-Abelleira A; Jorge-Barreiro J
    Br J Oral Maxillofac Surg; 2007 Oct; 45(7):573-5. PubMed ID: 17023100
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Remote effects of local injection of botulinum toxin type A].
    Wan X; Tang X; Cui L
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1999 Oct; 21(5):362-7. PubMed ID: 12567434
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Safety and efficacy of botulinum toxin therapy in otorhinolaryngology: experience from 1,000 treatments.
    Helmstaedter V; Wittekindt C; Huttenbrink KB; Guntinas-Lichius O
    Laryngoscope; 2008 May; 118(5):790-6. PubMed ID: 18300708
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Quantitative assessment of efficacy of dysport (botulinum toxin type A) in the treatment of idiopathic blepharospasm and hemifacial spasm.
    Tsai CP; Chiu MC; Yen DJ; Guo YC; Yuan CL; Lee TC
    Acta Neurol Taiwan; 2005 Jun; 14(2):61-8. PubMed ID: 16008164
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Management of spasticity and dystonia in children with acquired brain injury with rehabilitation and botulinum toxin A.
    Guettard E; Roze E; Abada G; Lemesle C; Vidailhet M; Laurent-Vannier A; Chevignard MP
    Dev Neurorehabil; 2009 Jun; 12(3):128-38. PubMed ID: 19466620
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Oromandibular dystonia involving the lateral pterygoid muscles: four cases with different complexity.
    Møller E; Bakke M; Dalager T; Werdelin LM
    Mov Disord; 2007 Apr; 22(6):785-90. PubMed ID: 17290453
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Natural history of posttraumatic cervical dystonia.
    Frei KP; Pathak M; Jenkins S; Truong DD
    Mov Disord; 2004 Dec; 19(12):1492-8. PubMed ID: 15390063
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Efficacy and safety of purified botulinum toxin type A (Dysport) for the treatment of benign essential blepharospasm: a randomized, placebo-controlled, phase II trial.
    Truong D; Comella C; Fernandez HH; Ondo WG;
    Parkinsonism Relat Disord; 2008; 14(5):407-14. PubMed ID: 18325821
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Botulinum toxin a in the treatment of chronic tension-type headache with cervical myofascial trigger points: a randomized, double-blind, placebo-controlled pilot study.
    Harden RN; Cottrill J; Gagnon CM; Smitherman TA; Weinland SR; Tann B; Joseph P; Lee TS; Houle TT
    Headache; 2009 May; 49(5):732-43. PubMed ID: 19178577
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Persistence of the synaptosomal-associated protein-25 cleavage product after intradetrusor botulinum toxin A injections in patients with myelomeningocele showing an inadequate response to treatment.
    Schulte-Baukloh H; Zurawski TH; Knispel HH; Miller K; Haferkamp A; Dolly JO
    BJU Int; 2007 Nov; 100(5):1075-80. PubMed ID: 17784887
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Use of botulinum toxin type A injection for neuropathic pain after trigeminal nerve injury.
    Yoon SH; Merrill RL; Choi JH; Kim ST
    Pain Med; 2010 Apr; 11(4):630-2. PubMed ID: 20210871
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The role of botulinum toxin type A in the radiation fibrosis syndrome: a preliminary report.
    Stubblefield MD; Levine A; Custodio CM; Fitzpatrick T
    Arch Phys Med Rehabil; 2008 Mar; 89(3):417-21. PubMed ID: 18295617
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Subcutaneous Botulinum toxin type A reduces capsaicin-induced trigeminal pain and vasomotor reactions in human skin.
    Gazerani P; Pedersen NS; Staahl C; Drewes AM; Arendt-Nielsen L
    Pain; 2009 Jan; 141(1-2):60-9. PubMed ID: 19004549
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.